期刊文献+

雌激素受体基因多态性与绝经后女性非酒精性脂肪性肝病的相关性研究

Correlation between polymorphism of estrogen receptor gene and non-alcoholic fatty liver disease in postmenopausal women
原文传递
导出
摘要 110例无亲缘关系绝经后女性非酒精性脂肪性肝病(NAFLD)患者和100名年龄相匹配的健康绝经后女性对照人群,采用限制性片段长度多态性聚合酶链反应(PCR—RFLP)方法对雌激素受体(ER)α和β基因多态性进行检测,并采用SHEsis在线计算平台进行单体型分析。结果显示,2组间ERdXbaI和Pvu1I酶切位点的基凶型及等位基凶分布频率差异无统计学意义(P〉0.05);而ERβRsaI和Alu I酶切位点的基因型及等位基因分布频率存在显著差异(P〈0.05或P〈0.01),携带R等位基因发生NAFLD的相对风险是r的1.833倍(95% CI 1.209~2.779.P〈0.01),携带α等位基因发生NAFLD的相对风险是A的1.782倍(95%CI1.037。3.061.P〈0.05)。r—A单体型在NAFLD组分布频率显著低于对照组(OR=0.529,95%CI 0.348~0.805)。Logistic回归分析显示,空腹血糖、甘油三酯、体重指数、舒张斥和AluI基因型与NAFI。D发生密切相关(均P〈0.01),与AA基因型相比,Aa/aa基因型NAFLD相对风险增加1.345倍(95% CI 1.028~2.505,P〈0.05)。 Genotypes of estrogen receptor gene (ER) α and β in 110 patients with non-alcoholic fatty liver disease (NAFLD) and 100 eontrol subjects were examined by polymerase chain reaction-based restriction fragment length polymorphism. The haplotype analysis was conducted by SHEsis on-line computing platform. The results showed that there were no differences in the genotype frequencies and allele frequencies of ERα at Xba I and Pvu Ⅱ enzyme cutting sites between two groups ( P〉 0.05 ). There existed significant differences in the genotype frequencies and allele frequencies of ERβ at Rsa I and Alu I enzyme cutting sites between these two groups ( P 〈 0. 05 or P 〈 0. 01 ). The risk of NAFLD in postmenopausal women with R or a allele was 1. 833 (95% CI 1. 209-2. 779, P〈0.05 ) or I. 782 ( 95 % CI 1. 037-3. 061 , P〈0.05 ) fold of that with allele r or A. The frequency of r-A haplotype in ERI3 was significantly lower in NAFLD group than that in control group ( OR = 0. 529,95% CI 0. 348-0. 805 ). Logistic regression analysis showed the relationship of fasting blood glucose, triglyceride, body mass index, diastolic pressure, Alu I genotype with NAFLI) ( all P〈O. 01 ). The risk of NAFLD in postmenopausal women with Aa/aa genotype was 1. 345 ( 95% CI 1. 028-2. 505, P〈0.05 ) folds of that with AA genotype.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2013年第9期788-791,共4页 Chinese Journal of Endocrinology and Metabolism
关键词 雌激素受体 基因多态性 单核苷酸 非酒精性脂肪性肝病 Estrogen receptors Polymorphism, single nucleotide Non-alcoholic fatty liver disease
  • 相关文献

参考文献3

二级参考文献34

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Ichiro Shimizu,Nao Kohno,Katsuyoshi Tamaki,Masayuki Shono,Hui-Wei Huang,Jiang-Hong He,Deng-Fu Yao.Female hepatology:Favorable role of estrogen in chronic liver disease with hepatitis B virus infection[J].World Journal of Gastroenterology,2007,13(32):4295-4305. 被引量:50
  • 3Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 4Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 5Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 6Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
  • 7Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
  • 8Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
  • 9Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.
  • 10Comar KM,Sterling RK.Drug therapy for non-alcoholic fatty liver disease.Aliment Pharmacal Ther,2006,23:207-215.

共引文献1545

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部